| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
|
Arch Gen Psychiatry
|
2006
|
11.84
|
|
2
|
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
|
Arch Gen Psychiatry
|
2010
|
4.85
|
|
3
|
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
|
J Clin Psychiatry
|
2010
|
2.98
|
|
4
|
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
|
Biol Psychiatry
|
2012
|
2.74
|
|
5
|
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.
|
Neuropsychopharmacology
|
2012
|
2.17
|
|
6
|
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.
|
Arch Gen Psychiatry
|
2006
|
2.09
|
|
7
|
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.
|
Arch Gen Psychiatry
|
2004
|
1.92
|
|
8
|
A double-blind, placebo-controlled study of memantine in the treatment of major depression.
|
Am J Psychiatry
|
2006
|
1.83
|
|
9
|
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
|
Biol Psychiatry
|
2012
|
1.76
|
|
10
|
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.
|
Bipolar Disord
|
2007
|
1.74
|
|
11
|
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.
|
J Clin Psychiatry
|
2003
|
1.72
|
|
12
|
Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist.
|
Biol Psychiatry
|
2008
|
1.71
|
|
13
|
Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies.
|
J Clin Psychiatry
|
2003
|
1.68
|
|
14
|
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.
|
Biol Psychiatry
|
2005
|
1.65
|
|
15
|
Reduced serotonin type 1A receptor binding in panic disorder.
|
J Neurosci
|
2004
|
1.61
|
|
16
|
Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.
|
J Clin Psychiatry
|
2008
|
1.57
|
|
17
|
Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects.
|
Am J Psychiatry
|
2005
|
1.55
|
|
18
|
Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects.
|
Biol Psychiatry
|
2005
|
1.51
|
|
19
|
Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
|
J Clin Psychiatry
|
2010
|
1.51
|
|
20
|
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor.
|
Mov Disord
|
2011
|
1.47
|
|
21
|
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
|
Biol Psychiatry
|
2012
|
1.47
|
|
22
|
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.
|
Bipolar Disord
|
2007
|
1.46
|
|
23
|
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.
|
Am J Psychiatry
|
2005
|
1.44
|
|
24
|
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.
|
J Clin Psychiatry
|
2003
|
1.44
|
|
25
|
Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.
|
Arch Gen Psychiatry
|
2008
|
1.42
|
|
26
|
Cerebral blood flow in immediate and sustained anxiety.
|
J Neurosci
|
2007
|
1.38
|
|
27
|
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
|
Biol Psychiatry
|
2013
|
1.31
|
|
28
|
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
|
Biol Psychiatry
|
2004
|
1.29
|
|
29
|
Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder.
|
Pediatrics
|
2006
|
1.29
|
|
30
|
Evidence for continuing neuropsychological impairments in depression.
|
J Affect Disord
|
2004
|
1.23
|
|
31
|
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
|
Annu Rev Pharmacol Toxicol
|
2014
|
1.21
|
|
32
|
Incidence of childhood-onset bipolar illness in the USA and Europe.
|
Br J Psychiatry
|
2008
|
1.21
|
|
33
|
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
|
Biol Psychiatry
|
2013
|
1.21
|
|
34
|
A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder.
|
J Clin Psychopharmacol
|
2012
|
1.20
|
|
35
|
Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression.
|
Biol Psychiatry
|
2002
|
1.18
|
|
36
|
Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder.
|
Neuroimage
|
2010
|
1.16
|
|
37
|
Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication.
|
Neuroimage
|
2009
|
1.16
|
|
38
|
Automated subcortical segmentation using FIRST: test-retest reliability, interscanner reliability, and comparison to manual segmentation.
|
Hum Brain Mapp
|
2012
|
1.14
|
|
39
|
Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.
|
Biol Psychiatry
|
2006
|
1.13
|
|
40
|
Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
|
Am J Psychiatry
|
2004
|
1.13
|
|
41
|
Regional cerebral glucose metabolic abnormalities in bipolar II depression.
|
Biol Psychiatry
|
2006
|
1.13
|
|
42
|
Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine.
|
Biol Psychiatry
|
2012
|
1.12
|
|
43
|
Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans.
|
Pharmacogenet Genomics
|
2005
|
1.10
|
|
44
|
Probing for hemispheric specialization for motor skill learning: a transcranial direct current stimulation study.
|
J Neurophysiol
|
2011
|
1.09
|
|
45
|
Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children.
|
J Affect Disord
|
2003
|
1.09
|
|
46
|
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2011
|
1.09
|
|
47
|
5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression.
|
Biol Psychiatry
|
2007
|
1.09
|
|
48
|
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.
|
Biol Psychiatry
|
2005
|
1.09
|
|
49
|
Reduced posterior hippocampal volume in posttraumatic stress disorder.
|
J Clin Psychiatry
|
2008
|
1.08
|
|
50
|
Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression.
|
Neuropsychopharmacology
|
2006
|
1.08
|
|
51
|
Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
|
J Clin Psychiatry
|
2010
|
1.06
|
|
52
|
Smaller head of the hippocampus in Gulf War-related posttraumatic stress disorder.
|
Psychiatry Res
|
2005
|
1.05
|
|
53
|
Performance on a virtual reality spatial memory navigation task in depressed patients.
|
Am J Psychiatry
|
2007
|
1.03
|
|
54
|
Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2010
|
1.03
|
|
55
|
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
|
J Clin Psychiatry
|
2008
|
1.02
|
|
56
|
On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human.
|
J Pharm Sci
|
2011
|
1.02
|
|
57
|
Emotion regulation and potentiated startle across affective picture and threat-of-shock paradigms.
|
Biol Psychol
|
2007
|
1.00
|
|
58
|
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
|
J Clin Psychiatry
|
2014
|
1.00
|
|
59
|
Clinical predictors of ketamine response in treatment-resistant major depression.
|
J Clin Psychiatry
|
2014
|
1.00
|
|
60
|
No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder.
|
Am J Psychiatry
|
2005
|
0.98
|
|
61
|
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
|
Int J Neuropsychopharmacol
|
2011
|
0.97
|
|
62
|
Differential performance on tasks of affective processing and decision-making in patients with Panic Disorder and Panic Disorder with comorbid Major Depressive Disorder.
|
J Affect Disord
|
2006
|
0.96
|
|
63
|
Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.
|
Bipolar Disord
|
2013
|
0.95
|
|
64
|
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.
|
Psychopharmacology (Berl)
|
2014
|
0.93
|
|
65
|
A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression.
|
Bipolar Disord
|
2008
|
0.93
|
|
66
|
Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder.
|
Biol Psychiatry
|
2009
|
0.93
|
|
67
|
Practitioner review: the assessment of bipolar disorder in children and adolescents.
|
J Child Psychol Psychiatry
|
2009
|
0.91
|
|
68
|
Baseline mood-state measures as predictors of antidepressant response to scopolamine.
|
Psychiatry Res
|
2012
|
0.89
|
|
69
|
Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.
|
Brain Res Bull
|
2011
|
0.89
|
|
70
|
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.
|
Bipolar Disord
|
2008
|
0.88
|
|
71
|
Perception of facial emotion in adults with bipolar or unipolar depression and controls.
|
J Psychiatr Res
|
2010
|
0.88
|
|
72
|
The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome.
|
J Neurochem
|
2011
|
0.88
|
|
73
|
Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
|
J Clin Psychiatry
|
2010
|
0.88
|
|
74
|
Decision-making and facial emotion recognition as predictors of substance-use initiation among adolescents.
|
Addict Behav
|
2009
|
0.87
|
|
75
|
Transcranial direct current stimulation for the treatment of focal hand dystonia.
|
Mov Disord
|
2011
|
0.86
|
|
76
|
Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders.
|
Biol Psychiatry
|
2002
|
0.86
|
|
77
|
Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence.
|
Alcohol Clin Exp Res
|
2012
|
0.86
|
|
78
|
Repetitive TMS combined with exposure therapy for PTSD: a preliminary study.
|
J Anxiety Disord
|
2008
|
0.84
|
|
79
|
A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
|
Eur Neuropsychopharmacol
|
2010
|
0.84
|
|
80
|
Early tobacco smoking in adolescents with externalizing disorders: inferences for reward function.
|
Nicotine Tob Res
|
2009
|
0.83
|
|
81
|
Processing of differentially valued rewards and punishments in youths with bipolar disorder or severe mood dysregulation.
|
J Child Adolesc Psychopharmacol
|
2008
|
0.82
|
|
82
|
Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease.
|
Neurorehabil Neural Repair
|
2012
|
0.82
|
|
83
|
Gender-specific abnormalities in the serotonin transporter system in panic disorder.
|
Int J Neuropsychopharmacol
|
2012
|
0.80
|
|
84
|
A magnetization transfer imaging study of corpus callosum myelination in young children with autism.
|
Biol Psychiatry
|
2012
|
0.80
|
|
85
|
Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.
|
J Affect Disord
|
2013
|
0.80
|
|
86
|
Neural correlates of sleepiness induced by catecholamine depletion.
|
Psychiatry Res
|
2011
|
0.78
|
|
87
|
Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A.
|
Neurosci Lett
|
2012
|
0.78
|
|
88
|
Unique design issues in clinical trials of patients with bipolar affective disorder.
|
J Psychiatr Res
|
2002
|
0.78
|
|
89
|
Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression.
|
J Affect Disord
|
2008
|
0.78
|
|
90
|
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?
|
Psychopharmacol Bull
|
2009
|
0.78
|
|
91
|
Low CSF somatostatin associated with response to nimodipine in patents with affective illness.
|
Biol Psychiatry
|
2003
|
0.76
|
|
92
|
Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
|
Int Clin Psychopharmacol
|
2007
|
0.76
|
|
93
|
Cerebral metabolic effects of intravenous glycine in healthy human subjects.
|
J Clin Psychopharmacol
|
2006
|
0.76
|
|
94
|
Early improvement with lithium in classic mania and its association with later response.
|
J Affect Disord
|
2012
|
0.76
|
|
95
|
Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
|
J Clin Psychiatry
|
2005
|
0.75
|